JPMORGAN CHASE & CO - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 169 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,476,123
+50.0%
586,759
+10.2%
0.00%
Q2 2023$1,650,844
+276.0%
532,530
+68.9%
0.00%
Q1 2023$439,000
+71749.4%
315,337
+2.7%
0.00%
Q4 2022$611
-99.9%
307,042
-16.8%
0.00%
Q3 2022$745,000
-37.4%
368,961
-1.5%
0.00%
Q2 2022$1,191,000
-21.4%
374,401
+3.0%
0.00%
Q1 2022$1,515,000
-12.8%
363,385
+0.2%
0.00%
Q4 2021$1,737,000
-13.2%
362,526
-3.2%
0.00%
Q3 2021$2,000,000
-3.1%
374,674
-7.0%
0.00%
Q2 2021$2,063,000
-27.7%
402,835
-5.0%
0.00%
Q1 2021$2,854,000
+28.0%
424,102
-13.0%
0.00%
Q4 2020$2,229,000
+1469.7%
487,672
+1219.0%
0.00%
Q3 2020$142,000
-11.2%
36,973
+10.1%
0.00%
Q2 2020$160,000
+17.6%
33,582
-13.8%
0.00%
Q1 2020$136,000
-33.3%
38,979
-7.9%
0.00%
Q4 2019$204,000
-78.9%
42,338
-87.3%
0.00%
Q3 2019$968,000
+172.7%
333,889
+567.3%
0.00%
Q2 2019$355,000
+5.7%
50,036
+110.7%
0.00%
Q1 2019$336,000
+0.9%
23,751
-3.5%
0.00%
Q4 2018$333,000
-37.9%
24,605
+1.9%
0.00%
Q3 2018$536,000
+52.3%
24,155
+12.8%
0.00%
Q2 2018$352,00021,4160.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$83,503,0007.34%
Eversept Partners, LP 2,656,208$10,306,0872.29%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$62,908,0001.13%
Prosight Management, LP 512,659$1,989,0000.95%
THB ASSET MANAGEMENT 833,104$3,232,0000.90%
GLOBEFLEX CAPITAL L P 251,696$977,0000.26%
XTX MARKETS LLC 10,243$40,0000.19%
HUSSMAN STRATEGIC ADVISORS, INC. 102,000$396,0000.10%
PA Capital LLC 33,874$132,0000.09%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 60,900$236,0000.07%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders